Altered calcium-homeostasis of cisplatin-resistant non small cell (NSLC) and small cell lung (SCLC) cancer cells

被引：3
|
作者：
Bergner, A. [1 ]
Schroedl, K. [1 ]
Oelmez, H. [1 ]
Huber, R. M. [1 ]
机构：
[1] Univ Munich, Med Klin Innenstadt, D-8000 Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.22185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22185
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells
    Wang, Huan
    Zhu, Xiaoli
    Huang, Jing
    Chen, Pingsheng
    Han, Shuhua
    Yan, Xing
    ONCOLOGY LETTERS, 2016, 11 (04) : 2566 - 2572
  • [2] The generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines
    Barr, M.
    O'Byrne, K. J.
    LUNG CANCER, 2010, 67 : S2 - S2
  • [3] Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells
    Ikuta, K
    Takemura, K
    Kihara, M
    Naito, S
    Lee, E
    Shimizu, E
    Yamauchi, A
    ONCOLOGY REPORTS, 2005, 13 (06) : 1229 - 1234
  • [4] Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
    Shoji, Tetsuaki
    Kikuchi, Eiki
    Kikuchi, Junko
    Takashima, Yuta
    Furuta, Megumi
    Takahashi, Hirofumi
    Tsuji, Kosuke
    Maeda, Makie
    Kinoshita, Ichiro
    Dosaka-Akita, Hirotoshi
    Sakakibara-Konishi, Jun
    Konno, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 843 - 853
  • [5] Immunoproteasome as a Potential Therapeutic Target in Cisplatin-Resistant Small and Non-Small Cell Lung Cancer
    Shoji, T.
    Kikuchi, E.
    Kikuchi, J.
    Maeda, M.
    Takashima, Y.
    Furuta, M.
    Takahashi, H.
    Kinoshita, I.
    Dosaka-Akita, H.
    Sakakibara-Konishi, J.
    Konno, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S705 - S705
  • [6] Evaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer
    Tetsuaki Shoji
    Eiki Kikuchi
    Junko Kikuchi
    Yuta Takashima
    Megumi Furuta
    Hirofumi Takahashi
    Kosuke Tsuji
    Makie Maeda
    Ichiro Kinoshita
    Hirotoshi Dosaka-Akita
    Jun Sakakibara-Konishi
    Satoshi Konno
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 843 - 853
  • [7] Altered Ca2+-homeostasis of cisplatin-treated and low level resistant non-small-cell and small-cell lung cancer cells
    Schroedl, Kathrin
    Oelmez, Hamza
    Edelmann, Martin
    Huber, Rudolf Maria
    Bergner, Albrecht
    CELLULAR ONCOLOGY, 2009, 31 (04) : 301 - 315
  • [8] Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells
    Shen, Daofu
    Wang, Yu
    Niu, Hongmei
    Liu, Chunying
    MOLECULAR MEDICINE REPORTS, 2020, 21 (03) : 1267 - 1275
  • [9] Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations
    Lopez-Ayllon, Blanca D.
    Moncho-Amor, Veronica
    Abarrategi, Ander
    Ibanez de Caceres, Inmaculada
    Castro-Carpeno, Javier
    Belda-Iniesta, Cristobal
    Perona, Rosario
    Sastre, Leandro
    CANCER MEDICINE, 2014, 3 (05): : 1099 - 1111
  • [10] Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
    Wang, Qi
    Zhong, Meizuo
    Liu, Wei
    Li, Jianhuang
    Huang, Jin
    Zheng, Le
    EXPERIMENTAL LUNG RESEARCH, 2011, 37 (07) : 427 - 434
12345